InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Lebwohl David, Vice-Président Exécutif et Responsable Médical. Officer active across 1 company, notably Intellia Therapeutics, Inc.. Aggregated, 18 disclosures have been recorded. Split: 0 buy · 4 sells. Total volume traded: €455k. History available since 9 August 2021. The latest transaction was filed on 1 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lebwohl David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
9,943 shares0Common StockSEC:0001193125-26-088258:0
11,903 shares@ US$9.2114.0% of flowCommon StockSEC:0001193125-26-006283:0
43,200 shares0Common StockSEC:0000950170-25-032125:0
9,557 shares@ US$12.1814.3% of flowCommon StockSEC:0000950170-25-003015:0
3,189 sharesCommon StockSEC:0000950170-25-001237:0
38,701 shares0Common StockSEC:0000950170-24-025904:0
5,843 shares@ US$29.4619.9% of flowCommon StockSEC:0000950170-24-002515:0
3,187 sharesCommon StockSEC:0000950170-24-001204:0
30,674 shares0Common StockSEC:0001209191-23-015753:0
2,574 shares@ US$37.2111.5% of flowCommon StockSEC:0001209191-23-002417:0
3,187 sharesCommon StockSEC:0001209191-23-001492:0
3,187 sharesCommon StockSEC:0001209191-22-015960:0
2,400 shares@ US$12.623.9% of flowCommon StockSEC:0001209191-21-063698:0
2,400 shares@ US$12.623.9% of flowCommon StockSEC:0001209191-21-060638:0
7,923 shares@ US$12.6212.7% of flowCommon StockSEC:0001209191-21-057778:0
2,400 shares@ US$12.623.9% of flowCommon StockSEC:0001209191-21-057475:0
2,400 shares@ US$12.623.8% of flowCommon StockSEC:0001209191-21-054317:0
2,400 shares@ US$12.623.9% of flowCommon StockSEC:0001209191-21-050881:0
18 of 18 declarations
About Lebwohl David
Lebwohl David is Executive Vice President and Chief Medical Officer at Intellia Therapeutics, Inc. He has 18 filings in total. Across the 18 sampled recent filings, the period runs from 2021-08-11 to 2026-03-03, with €0 of buys and €455156 of sells. The most common transaction type is option exercise.
